496 results on '"Trépo, Christian"'
Search Results
2. Update of the statements on biology and clinical impact of occult hepatitis B virus infection
3. 29 Hépatite chronique virale B : nouvelles perspectives thérapeutiques
4. Extrahepatic Manifestations of Chronic Hepatitis B Infection
5. Hepatitis C in Laos: A 7-Year Retrospective Study on 1765 Patients
6. Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion
7. A 42-Week Open-Label Study to Assess the Pharmacokinetics, Antiretroviral Activity, and Safety of Amprenavir or Amprenavir plus Ritonavir in Combination with Abacavir and Lamivudine for Treatment of HIV-Infected Patients
8. Smoking and Non-Hodgkin's Lymphoma: A Case-Control Study in the Rhône-Alpes Region of France
9. Infection of a Human Hepatoma Cell Line by Hepatitis B Virus
10. Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases
11. Hepatitis B virus infection
12. Predictors of the therapeutic response in hepatitis C. A 2013 update
13. Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA)
14. Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
15. Probable Corticosteroid-Induced Reactivation of Latent Hepatitis B Virus Infection in an HIV-Positive Patient Involving Immune Escape
16. Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment
17. Base Pairing in the Pregenome Encapsidation Signal of HBV: A Clue for the Prevalence of Naturally Occurring HBeAg-minus Precore Mutations
18. Duck Hepatocellular Carcinoma from a High Incidence Area: Analysis for Duck Hepatitis B Virus Infection and p53 Mutation
19. Integrated Viral Sequences may Contribute in cis and in trans to Hepatocarcinogenesis in Woodchuck Hepatitis Virus-infected Woodchucks
20. Quantification and Functional Analysis of Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C Virus Infection
21. Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
22. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
23. A New Viral Agent, SEN Virus (SENV), Has Been Detected in Patients from Several Countries: The Pathogenic Role of SENV in Coinfections with Hepatitis B Virus or Hepatitis C Virus Should Be Investigated
24. The 2020 Nobel prize of Medicine for three hepatitis C discovery pioneers: a medical history milestone
25. Evolution of Hepatitis B Virus Polymerase Gene Sequence during Famciclovir Therapy for Chronic Hepatitis B
26. Waterborne Outbreak of Intestinal Microsporidiosis in Persons with and without Human Immunodeficiency Virus Infection
27. Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island
28. Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
29. Extrahepatic Manifestations of Hepatitis B Infection
30. Effect of Prolonged Interferon Therapy on the Outcome of Hepatitis C Virus–Related Cirrhosis: A Randomized Trial
31. Traitement d’entretien
32. Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins
33. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
34. Current Management Strategies for Hepatitis B in the Elderly
35. Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases
36. Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis: (Paris, France, January 12–14, 2006)
37. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes
38. Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)
39. Evolution of Hepatitis B and C serum markers: a still challenging issue
40. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes
41. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C
42. Association of Anti-E1E2 Antibodies with Spontaneous Recovery or Sustained Viral Response to Therapy in Patients Infected with Hepatitis C Virus
43. Inhibition of the Binding of HCV Serum Particles to Human Hepatocytes by E1E2-Specific D32.10 Monoclonal Antibody
44. Clearance of Serum HBsAg and Anti-HBs Seroconversion Following Antiviral Therapy for Chronic Hepatitis B
45. Prediction of the Virological Response to Etravirine in Clinical Practice: Comparison of Three Genotype Algorithms
46. Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing
47. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo
48. Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA)
49. Interferon Treatment of Viral Hepatitis: Practical Recommendations
50. 29. Hépatite C : perspectives thérapeutiques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.